Portal de Periódicos da CAPES

TopBP1 deficiency impairs V(D)J recombination during lymphocyte development

2014; Springer Nature; Linguagem: Inglês

10.1002/embj.201284316

1460-2075

Ji‐Eun Kim, Sung Kyu Lee, Yoon Jeon, Ye-Hyun Kim, Changjin Lee, Sung Ho Jeon, Jaegal Shim, In-Hoo Kim, Seokmann Hong, Nayoung Kim, Ho Lee, Rho Hyun Seong,

Ubiquitin and proteasome pathways

Article18 January 2014free access TopBP1 deficiency impairs V(D)J recombination during lymphocyte development Jieun Kim Jieun Kim Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Sung Kyu Lee Sung Kyu Lee Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Yoon Jeon Yoon Jeon Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea Search for more papers by this author Yehyun Kim Yehyun Kim Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Changjin Lee Changjin Lee Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Sung Ho Jeon Sung Ho Jeon Departement of Life Science, Hallym University, Chuncheon, Korea Search for more papers by this author Jaegal Shim Jaegal Shim Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author In-Hoo Kim In-Hoo Kim Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author Seokmann Hong Seokmann Hong Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul, Korea Search for more papers by this author Nayoung Kim Nayoung Kim Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea Search for more papers by this author Ho Lee Corresponding Author Ho Lee Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author Rho Hyun Seong Corresponding Author Rho Hyun Seong Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Jieun Kim Jieun Kim Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Sung Kyu Lee Sung Kyu Lee Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Yoon Jeon Yoon Jeon Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea Search for more papers by this author Yehyun Kim Yehyun Kim Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Changjin Lee Changjin Lee Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Sung Ho Jeon Sung Ho Jeon Departement of Life Science, Hallym University, Chuncheon, Korea Search for more papers by this author Jaegal Shim Jaegal Shim Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author In-Hoo Kim In-Hoo Kim Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author Seokmann Hong Seokmann Hong Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul, Korea Search for more papers by this author Nayoung Kim Nayoung Kim Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea Search for more papers by this author Ho Lee Corresponding Author Ho Lee Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea Search for more papers by this author Rho Hyun Seong Corresponding Author Rho Hyun Seong Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea Search for more papers by this author Author Information Jieun Kim1, Sung Kyu Lee1, Yoon Jeon2,3, Yehyun Kim1, Changjin Lee1, Sung Ho Jeon4, Jaegal Shim2, In-Hoo Kim2, Seokmann Hong5, Nayoung Kim6, Ho Lee 2 and Rho Hyun Seong 1 1Department of Biological Sciences, Institute of Molecular Biology and Genetics, Research Center for Functional Cellulomics, Seoul National University, Seoul, Korea 2Division of Convergence Technology, Research Institute, National Cancer Center, Goyang, Korea 3Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea 4Departement of Life Science, Hallym University, Chuncheon, Korea 5Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul, Korea 6Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea *Corresponding author. Tel: 82 2 880 7567; Fax: 82 2 887 9984; E-mail: [email protected] The EMBO Journal (2014)33:217-228https://doi.org/10.1002/embj.201284316 PDFDownload PDF of article text and main figures. Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Abstract TopBP1 was initially identified as a topoisomerase II-β-binding protein and it plays roles in DNA replication and repair. We found that TopBP1 is expressed at high levels in lymphoid tissues and is essential for early lymphocyte development. Specific abrogation of TopBP1 expression resulted in transitional blocks during early lymphocyte development. These defects were, in major part, due to aberrant V(D)J rearrangements in pro-B cells, double-negative and double-positive thymocytes. We also show that TopBP1 was located at sites of V(D)J rearrangement. In TopBP1-deficient cells, γ-H2AX foci were found to be increased. In addition, greater amount of γ-H2AX product was precipitated from the regions where TopBP1 was localized than from controls, indicating that TopBP1 deficiency results in inefficient DNA double-strand break repair. The developmental defects were rescued by introducing functional TCR αβ transgenes. Our data demonstrate a novel role for TopBP1 as a crucial factor in V(D)J rearrangement during the development of B, T and iNKT cells. Synopsis TopBP1 is needed for V(D)J rearrangement during development of B, T and iNKT cells. TopBP1 is highly expressed during lymphocyte development. Deletion of TopBP1 leads to immune deficiency and the lack of mature B and T cells. Ablation of TopBP1 results in increased double strand breaks due to inefficient V(D)J recombination. These defects are rescued by expressing pre-rearranged TCR transgenes, supporting that TopBP1 plays a role during V(D)J recombination. . Introduction Adaptive immunity is based on the ability of B and T cells to recognize and ultimately eliminate a plethora of foreign invaders from the host. An individual has billions of B and T cells and each conventional B and T cell expresses a B-cell receptor (BCR) or T-cell receptor (TCR) that recognizes a single antigen. The combinatorial assembly of a limited number of BCR and TCR genes by rearrangement gives rise to the diversity of the BCR and αβ TCR repertoire. The processes of B-cell and T-cell development are very similar, except that T progenitor cells migrate to the thymus via the blood to acquire T-cell identities. Lymphocytes originate from multipotent stem cells in the fetal liver before, and in the bone marrow after birth. Common lymphoid progenitors (CLPs) differentiate to late pro-B cells after passing through pre-pro (Fr. A) and early-pro stages (Fr. B). Early-pro-B cells rearrange the immunoglobulin (Ig) heavy chain, and late-pro-B cells (Fr. C) express pre-B-cell receptor (pre-BCR) on the cell surface. Pre-BCR signaling results in a burst of proliferation and the differentiation of pro-B cells to pre-B cells. The earliest thymic progenitor cells express neither CD4 nor CD8 co-receptors (the double-negative (DN) stage) (Godfrey et al, 1993). DN thymocytes are briefly arrested at late DN2 stage to rearrange the TCRβ locus. After a set of somatic DNA rearrangements, a functional TCRβ chain associates with pTα and CD3 complex to form the pre-TCR complex (von Boehmer & Fehling, 1997; von Boehmer et al, 1999). Cells that fail to produce a functional pre-TCR are eliminated by apoptosis. Therefore, pre-TCR deficient RAG−/− (Mombaerts et al, 1992b; Shinkai et al, 1992), TCRβ−/− (Mombaerts et al, 1992a), pTα−/− (Fehling et al, 1995) and CD3−/− (Love et al, 1993; Malissen et al, 1993) mice have a developmental block at the DN3 stage. The pre-TCR signaling at the DN3 stage is critical for differentiation into the CD4+CD8+ double-positive (DP) stage. Most DP thymocytes further develop into mature CD4 or CD8 single-positive (SP) thymocytes. On the other hand, iNKT cells branch away from the conventional T-cell lineage at the DP stage and proceed through defined developmental stages (Benlagha et al, 2002). Although conventional T cells express a diverse repertoire of TCRβ and TCRα, iNKT cells combine only the Vα14 TCRα chain with a restricted repertoire of TCRβ proteins. Diverse and functional receptors are produced by V(D)J recombination and this process is initiated by the lymphoid-specific recombinase (RAG, composed of RAG1 and RAG2). RAG proteins create double-strand breaks (DSBs) at recombination signal sequences (RSSs) that flank each variable (V), diversity (D) and joining (J) gene segment to release blunt signal ends and hairpin coding ends (Bassing et al, 2002; Schatz & Spanopoulou, 2005). These breaks are subsequently resolved via the nonhomologous end joining (NHEJ) pathway, one of the DSB repair pathways (Gellert, 2002). XRCC4, Ku70, Ku80, Ligase IV and XLF/Cernunnos are components of the NHEJ machinery. The blunt signal ends are simply joined to form precise signal joints whereas the hairpin coding ends must be opened by the Artemis/DNA-PK complex before ligation can take place (Bassing et al, 2002; Schatz & Spanopoulou, 2005; Dahm, 2008). The lesions introduced by RAG proteins are considered to be among the most dangerous lesions, because they present threats to genome stability. Therefore, elaborate mechanisms are crucial to ensure efficient DSB repair. TopBP1 is topoisomerase II-β-binding protein with eight BRCT (the C-terminal domain of a breast cancer susceptibility protein) motifs that are found in proteins involved in DNA replication, DNA damage response, and cell cycle checkpoints (Bork et al, 1997; Callebaut & Mornon, 1997). TopBP1 is a substrate of Ataxia telangiectasia mutated (ATM) (Yamane et al, 2002), which coordinates DSB repair through its ability to phosphorylate its substrates including Mre11, Rad50, BRCA1, DNA-PK, 53BP1, H2AX, and p53 (Keimling et al, 2011). ATM-deficient mice display a reduction in number of mature CD4 and CD8 cells (Barlow et al, 1996). T-cell number and function were rescued by introducing functional TCR αβ transgene, indicating that a defect in TCR recombination is responsible for the impaired T-cell development (Chao et al, 2000). TopBP1 is also known to bind to Nbs1, a component of the MRN complex which is involved in DNA DSB repair in mammals (Carney et al, 1998; Chen et al, 2000). TopBP1 colocalizes with Nbs1 following DNA damage (Yamane et al, 2002), and TopBP1-depleted cells display a reduced frequency of sister chromatid exchange (SCE), suggesting that TopBP1 plays a role in double-stranded DNA break-induced homologous recombination (HR) repair in association with Nbs1 (Morishima et al, 2007). Nbs1-deficient mice also showed defects in lymphoid development resulting in immune deficiency (Kang et al, 2002). Thus, it is conceivable that TopBP1 has a critical role in V(D)J recombination during lymphocyte development. Here we report that TopBP1 is a new critical factor for V(D)J recombination occurring during lymphocyte development. Results Expression of TopBP1 in early lymphocytes We first determined the expression profile of TopBP1 in various tissues using Western blot analysis. TopBP1 is highly expressed in the lymphoid tissues (Supplementary Fig S1A). In B-cell subpopulations, Topbp1 is abundant in pro- and pre-B cells when compared to immature and mature B cells (Supplementary Fig S1B). In the thymus, expression of Topbp1 is induced at the DN2 stage, maintained at a high level until the DP stage, and down-regulated when thymocytes reach maturity (Supplementary Fig S1C). Thus, the Topbp1 expression patterns suggest that it may be required for early lymphocyte development. The loss of TopBP1 leads to embryonic lethality at an early stage (Jeon et al, 2011). Thus, we used mice conditionally deficient in TopBP1 expression and investigated the function of TopBP1 in lymphocyte development. Deletion of TopBP1 results in profound immune deficiency in B cells The role of TopBP1 in B-cell development was investigated using TopBP1f/f mice crossed with Mb1-cre mice. Deficiency of TopBP1 in early B-cell progenitors resulted in a significant decrease in both the percentage and number of B cells, characterized by surface expression of B220 and CD19 in the bone marrow, spleen, and peripheral blood cells (Fig 1A). B-cell lymphopoiesis can be subdivided using cell-surface markers according to the classification proposed by Hardy and colleagues (Hardy et al, 1991). As shown Fig 1B, most B220+ cells present in the bone marrow of TopBP1-deficient mice were pro-B cells (Fr. A-C) and very few exhibited a pre-B-cell phenotype. These results imply that the ablation of TopBP1 impaired B-cell development during or before the pro-B cell stage. Further subfractionation of pro-B-cell populations revealed a significant increase in the percentage of CD24−BP1− cells (Fr. A) in TopBP1-deficient mice (Fig 1C). However, pre-pro-B (Fr. A) cells were clearly quantitatively preserved in the absence of TopBP1, suggesting a critical role for TopBP1 at early-pro-B-cell stage (Fr. B). Figure 1. TopBP1 deficiency results in B cell immune deficiency Flow cytometric analysis of CD19 and B220 expression on bone marrow, spleen and peripheral blood cells from control and TopBP1-deficient mice (n = 3). Absolute cell numbers of CD19+B220+ cells are shown (bottom). B220+IgM− cells were analyzed for expression of B220 and CD43. Expression of BP-1 and CD24 on pro-B cells are shown, with percentages of Fr. A, B, and C. Download figure Download PowerPoint Impaired early T-cell development in TopBP1-deficient mice Roles of TopBP1 during thymocyte development were also investigated by analyzing thymi from TopBP1f/d mice crossed with Lck-cre mice. TopBP1-deficient mice showed approximately a seven-fold reduction in the total cellularity of thymocytes compared to littermate controls (Supplementary Fig S2A and B). They did not display clear demarcations between the cortex and medullar regions (Supplementary Fig S2C). The percentage of DN cells was markedly increased, but the actual number of DN cells from TopBP1-deficient mice was not substantially different from that of littermate controls (Fig 2A). Both the percentage and the actual cell number of DP thymocytes and mature SP thymocytes were reduced, suggesting that there was a major developmental block between the DN and DP stages. Total cellularity of spleen and lymph nodes from TopBP1-deficient mice was also significantly reduced compared to that of littermate controls, reflecting the greatly reduced generation of mature SP thymocytes (Supplementary Fig S2D). However, non-T cells in peripheral organs were not affected by the T lineage cell-specific TopBP1 deficiency (Supplementary Fig S2E). Figure 2. Block in early lymphocyte development in the absence of TopBP1 Percentages and absolute cell numbers (bottom) of DN, DP, CD4, and CD8 cells (n = 14). Expression of CD25 and CD44 on DN thymocytes with the percentages of DN1–4 subsets. Expression of CD27 in DN3 and DN4 thymocytes. Analysis of surface (left) and intracellular (right) TCRβ in DN3 and DN4 thymocytes. Data shown represent four independent experiments with similar results. Download figure Download PowerPoint When DN thymocytes were stained for CD25 and CD44 surface markers to pinpoint more precisely the DN stage at which TopBP1 was required, we found that TopBP1 deficiency led to the accumulation of thymocytes at the DN3 stage (Fig 2B). The DN3/DN4 ratio showed a more than a three-fold increase in TopBP1-deficient mice (Supplementary Fig S3). The proportion of CD44intCD25bright cells significantly increased in the TopBP1-deficient DN compartment (Supplementary Fig S2F). These populations are normally present in mice bearing defects in pre-TCR signaling, such as pTα−/−, TCRβ−/−, Rag1−/−, and CD3ε−/− mice. The presence of a large number of CD25bright DN3 cells may be due to one of the following reasons; deficiency of one of the pre-TCR components, problems in pre-TCR signaling, or defects in proliferation and survival. We stained DN3 and DN4 thymocytes for the CD27 surface marker to see how many cells properly went through β-selection (Fig 2C), which results in an upregulation of expression of CD27. These post-β-selected DN3 cells are classified as DN3b and the CD27low pre-β-selected DN3 cells as DN3a (Taghon et al, 2006). The relatively low expression of CD27 in both DN3 and DN4 cells from TopBP1-deficient mice suggests that the developmental arrest at the DN3 stage might be due to defects during β-selection. Next, we determined whether TopBP1 influences the formation of the pre-TCR complex with CD3 components. We found that surface CD3 expression and pTα mRNA level were not affected (Supplementary Fig S4A and B). However, we found that TopBP1-deficient mice had a decreased percentage and number of surface and intracellular TCRβ+ thymocytes (Fig 2D). Thus, the developmental block at the DN3 stage was mainly due to defective expression of TCRβ. Since thymus cellularity was greatly reduced and developmental blocks were seen at the DN3–DN4 and the DN–DP transitions in TopBP1-deficient mice, we also examined the cell survival of TopBP1-deficient thymocytes. Increased Annexin V+ thymocytes were detected in DN3 and DN3–DN4 subpopulations, suggesting increased cell death of TopBP1-deficient cells (Supplementary Fig S5A). This was further confirmed in vitro using the OP9-DL1 co-culture system (Notch ligand Delta-like-1 transduced OP9 cells) (Schmitt & Zuniga-Pflucker, 2002; Schmitt et al, 2004; de Pooter et al, 2006). Purified DN3a cells from TopBP1-deficient mice and littermate controls were cultured on OP9-DL1 monolayers for 7 days. The DP population was severely reduced when TopBP1-deficient DN3a cells, rather than control cells, were co-cultured with OP9-DL1 stromal cells (Supplementary Fig S5B). Fewer DN3a cells from TopBP1-deficient mice than from controls progressed to DN3b, since the CD27 expression remained relatively lower in the TopBP1-deficient mice (Supplementary Fig S5C). This defect in the DN3a to DN3b transition in TopBP1-deficient cells appeared to be due to both decreased proliferation and increased cell death during β-selection. When we cultured DN3a cells from littermate control mice after stably labeling with carboxyfluorescein succinimidyl ester (CFSE), each cell division resulted in a sequential halving of fluorescence, which was not observed for DN3a cells from TopBP1-deficient mice (Supplementary Fig S5D). These results suggest that TopBP1-deficient DN3 thymocytes are less proliferative, which may contribute to the perturbation of development and maturation of thymocytes. Impaired maturation of SP thymocytes and iNKT development in TopBP1-deficient mice Next, we investigated the role of TopBP1 in the production of mature CD4 and CD8 SP thymocytes. We crossed mice with a floxed allele of TopBP1 with CD4-cre mice, since very early inactivation of TopBP1 in DN thymocytes using Lck-cre mice leads to defects during the transition from DN to DP stage, thereby severely reducing thymic cellularity. The numbers of mature CD4 and CD8 SP cells were significantly reduced in TopBP1-deficient mice (Fig 3A). Since commitment to iNKT-cell lineages as well as to CD4 and CD8 T-cell lineages is determined during the DP stage, we examined whether TopBP1 is required for iNKT-cell development. We stained thymocytes with CD1d-tet and TCRβ to evaluate iNKT-cell populations in the thymus, liver, and spleen. We observed significantly smaller numbers and frequency of iNKT cells in the thymus, spleen, and liver of TopBP1-deficient mice compared to those of controls (Fig 3B). Figure 3. TopBP1 is required for iNKT-cell development Percentages of DN, DP, CD4 and CD8 cells (n = 7). Expression of CD1d-tet and TCRβ in the thymus, liver and spleen from control and TopBP1-deficient mice (n = 4). Absolute cell numbers of iNKT cells are shown (bottom). Expression of CD44/NK1.1 (top) and CD24 (bottom) in CD1d-tet+TCRβint cells. Download figure Download PowerPoint To determine precisely the stages of iNKT-cell development perturbed by the absence of TopBP1, we analyzed developmental subsets on the basis of expression of CD24, CD44 and NK1.1. This analysis showed a severe reduction in stage 2 and 3 cells, indicating that the developmental block occurred during stages 0 and 1. As shown Fig 3C, most iNKT cells in the thymus of TopBP1-deficient mice were CD24high. These results suggest that ablation of TopBP1 impairs iNKT-cell development at stage 0, indicating that they have not yet received the positive selection signal. We analyzed CD1d expression on DP thymocytes to determine whether the skewing toward stage 0 cells was due to diminished CD1d expression. Control and TopBP1-deficient thymocytes expressed similar amounts of CD1d (Supplementary Fig S6A and B). In addition, mRNA expression of Bcl-xl, the main factor controlling DP survival, did not show any significant differences between control and TopBP1-deficient DP thymocytes, suggesting that TopBP1 deficiency does not influence the survival of DP thymocytes (Supplementary Fig S6C). Therefore, decreased survival of DP cells of TopBP1-deficient mice was not the main reason for the block in iNKT-cell development. Inefficient V(D)J recombination in TopBP1-deficient cells From our results showing the developmental block at the time of IgH gene rearrangement during B-cell development, decrease in expression of TCRβ and impaired maturation of SP thymocytes in T-cell development, and the defects in early iNKT-cell differentiation, we deduced that TopBP1 could be involved in the V(D)J rearrangement process. Thus, we investigated whether ablation of TopBP1 affects V(D)J rearrangement. Genomic DNA from sorted pro-B cells of control and TopBP1-deficient mice was extracted and analyzed for VH52 and VH558 with J rearrangements. We observed that both VH52-JH3 and VH558-JH3 rearrangements were largely absent (Fig 4A). To see whether the recombination events were normal, we sequenced V(D)J rearrangements from control and Mb1-cre; TopBP1f/f mice pro-B cells. Although V(D)J rearrangement of Ig is significantly decreased in TopBP1-deficient pro-B cells, we observed no apparent differences in the fidelity of the coding joints between these two populations (Supplementary Table S5). It is not yet clear whether the overall normality of V(D)J rearrangement sequences is due to TopBP1-sufficient cells resulting from incomplete deletion or because TopBP1 is dispensable for these processes. Figure 4. Inefficient V(D)J recombination in TopBP1-deficient mice V(D)J recombination analyses of genomic DNA from purified pro-B cells (B220+CD43+IgM−) of control and TopBP1-deficient mice. Cμ was amplified as a loading control. Genomic DNA was isolated from sorted DN3 and DN4 thymocytes, from control and TopBP1-deficient mice. Serially diluted genomic DNA was assayed for V(D)J recombination in DN3 and DN4 thymocytes. Thy1 was amplified as a loading control. The experiments were repeated at least three times with consistent results. Vα rearrangement of purified DP cells was measured by semi-quantitative PCR. Cα was amplified as a loading control. Download figure Download PowerPoint The absence of TopBP1 also affected the rearrangement of TCR genes in a similar way to Ig rearrangement. Because of low expression of TCRβ in thymocytes, we purified genomic DNA from fractionated DN3 and DN4 cells and amplified across Vβ5.1 and Vβ8.2 segments by using PCR. There was a significant decrease in the V(D)J rearrangement of TCRβ in TopBP1-deficient thymocytes compared to control cells (Fig 4B). Also, using semi-quantitative PCR to detect TCRα rearrangements, we found that pre-selected DP thymocytes from TopBP1-deficient mice showed inefficient rearrangements, including Vα14-Jα18 (Fig 4C). In order to assess the function of TopBP1 in V(D)J recombination in vitro, a DNA for shRNA-targeting TopBP1 (shTopBP1) was cloned into the retroviral vector MDH (Supplementary Fig S7A). NIH3T3 cells were infected with either MDH-shTopBP1 or empty MDH vector, and in vitro recombination assays were performed. We purified GFP+ cells from these MDH or MDH-shTopBP1-infected NIH3T3 cells. Western blotting assay confirmed that TopBP1 expression was reduced in MDH-shTopBP1-infected cells relative to MDH-infected NIH3T3 cells (Fig 5A). These cells were then transiently co-transfected with murine RAG1 and RAG2 expression vectors, as well as the extrachromosomal recombination substrate pJH289 and pJH290 (Deriano et al, 2009) (Supplementary Fig S7B). This system provides a specific RAG1/2-mediated V(D)J recombination model in non-lymphoid cells. Coding joints and signal joints were produced inefficiently in TopBP1-deficient cells (Fig 5B). Figure 5. Aberrant V(D)J recombination and persistence of γ-H2AX around DSB sites in TopBP1-deficient cells Reduction of TopBP1 expression by shRNA-TopBP1 retrovirus. β-actin served as a loading control. PCR-based in vitro recombination assay using recombination substrates and RAG expression vectors transfected into either control or shTopBP1 retrovirus-infected NIH3T3 cells (n = 3). Transfectants without RAG1 and RAG2 served as a negative control. Real-time PCR analysis showing levels of Rag1, Rag2, Ku70, Ku80, Xrcc4, Lig4, and Dna-pk transcripts relative to β-actin control detected in cDNA prepared from purified control and TopBP1-deficient DN3 thymocytes (n = 4). ChIP analysis using antibodies against TopBP1 and IgG. These antibodies recovered the Vβ region of WT (wild-type) thymocytes. PCR product of Gapdh intron served as a negative control. The data are representative of three experiments. γ-H2AX accumulates in TopBP1-deficient DN3 cells. ChIP analysis using antibody against γ-H2AX. This antibody recovered the Vβ region of WT and TopBP1-deficient DN3 cells. PCR product of Gapdh intron served as a negative control. Download figure Download PowerPoint Impaired V(D)J recombination in TopBP1-deficient lymphocytes and NIH3T3 cells may be due to insufficient expression of components necessary for V(D)J recombination. To test this, we isolated DN3 and DN4 cells and measured mRNA levels of factors involved in the V(D)J recombination. mRNAs for Rag1, Rag2, ku70, ku80, Xrcc4, Ligase4 and Dna-pk were expressed normally in TopBP1-deficient cells (Fig 5C). Incomplete repair of DNA DSBs in TopBP1-deficient cells Even though NHEJ family, Rag1 and Rag2 are expressed normally in TopBP1-deficient cells, V(D)J rearrangement was found to be reduced. To further verify that TopBP1 is actually involved in V(D)J recombination, we analyzed the DSB repair status around RAG-induced DSB sites by ChIP analysis using the TopBP1 antibody. We found that TopBP1 was loaded on DSBs of the TCR Vβ segment, at the very site of V(D)J recombination (Fig 5D). Histone H2AX is rapidly phosphorylated specifically at serine 139 (γ-H2AX) after exposure to DNA damaging agents which is a hallmark of DSBs (Rogakou et al, 1998; Banath & Olive, 2003; Pilch et al, 2003). γ-H2AX foci were accumulated in TopBP1-deficient DN3 cells compared to control cells (Fig 5E). We also examined the H2AX phosphorylation status around RAG-induced DSB sites by ChIP analysis using TopBP1-deficient and control thymocytes. We precipitated greater amount of γ-H2AX products from V regions of TCRβ loci in TopBP1-deficient DN3 cells than those from controls (Fig 5F). It is possible that genomic instability exists due to increased γ-H2AX. Abnormal chromosomes are significantly increased in TopBP1-deficient thymocytes when compared to control cells (Supplementary Fig S8). Because TopBP1 interacts with NBS1, we performed DuoLink assay to see whether NBS1 is recruited to the γ-H2AX foci in TopBP1-deficient cells. We found that NBS1 interacts with γ-H2AX even in the absence of TopBP1 (supplementay Fig S9). Transgenic TCR overcomes the developmental defects caused by TopBP1 ablation Our results suggest that reduced thymic cellularity was due to a DN3 arrest, which was caused by defective TCRβ expression. To confirm this, we tested